as 11-14-2024 11:36am EST
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
Upcoming Earnings Alert:
Get ready for potential market movements as BiomX Inc. COmmon Stock PHGE prepares to release earnings report on 19 Nov 2024.
Founded: | 2015 | Country: | Israel |
Employees: | N/A | City: | GAITHERSBURG |
Market Cap: | 26.5M | IPO Year: | N/A |
Target Price: | $22.50 | AVG Volume (30 days): | 148.1K |
Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -4.14 | EPS Growth: | N/A |
52 Week Low/High: | $0.62 - $8.55 | Next Earning Date: | 11-19-2024 |
Revenue: | N/A | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
PHGE Breaking Stock News: Dive into PHGE Ticker-Specific Updates for Smart Investing
GlobeNewswire
6 hours ago
GlobeNewswire
2 days ago
TipRanks
a month ago
GlobeNewswire
a month ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
2 months ago
GlobeNewswire
3 months ago
The information presented on this page, "PHGE BiomX Inc. COmmon Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.